OrbusNeich Medical v. Boston Scientific
This article was originally published in The Gray Sheet
Hong Kong stent developer OrbusNeich sues Boston Scientific in Alexandria, Va., federal court March 16, alleging that the latter firm's Liberté stent infringes two OrbusNeich patents for luminal stent technology. The patents are entitled "Stent Having Helical Elements" (no. 7,329,277) and "Crimpable Intraluminal Endoprosthesis Having Helical Elements" (no. 6,821,292). The charges also include breach of contract and misappropriation of trade secrets stemming from a July 2000 confidential disclosure agreement between the firms related to a potential business relationship. The suit seeks unspecified monetary damages and injunctive relief
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”